- EASI Genomics was launched on the 1st February 2019 and opens its 1st call for proposal today.
- Sixteen project partners gathered on 18th February 2019 for the kick-off meeting of EASI Genomics, a new European funded project to provide easy access to sequencing technologies and analysis to researchers.
- In addition to providing free-of-charge transnational access to advanced sequencing technologies, EASI-Genomics aims at building a community of practice which leverages advanced sequencing technologies beyond country and sector borders to tackle global challenges in science.
The European Advanced infraStructure for Innovative Genomics (EASI-Genomics), a project funded under the European Union’s research and innovation programme Horizon 2020, will provide researchers free-of-charge access to cutting-edge European genomics facilities. EASI-Genomics joins 16 academic and industrial partners to support diverse genomics project from study design, over state-of-the-art sequencing to bioinformatic analysis. EASI-Genomics is an infrastructure project with a total budget of 10 million € that will handle between 150 and 300 projects over a period of 4 years. Ivo Gut from the Centro Nacional de Análisis Genómico of the Centre for Genomic Regulation (CNAG-CRG) coordinates the project.
The first call for proposals will focus on sequencing of ancient DNA from archaeological samples, analysis of microbiomes that study the diversity and particularities of populations of microorganisms related to diseases, the study of genetic material at single cell level, and epigenetic modifications of genetic material and its organisation in human diseases. This first call is launched today, 25th March (www.easi-genomics.eu). EASI-Genomics represents a great opportunity for researchers to access high-end sequencing services delivered by European genomics infrastructures of excellence free-of-charge.
The project started with a kick-off meeting on 18th and 19th February 2019 in Barcelona, Spain. Apart from providing easy and seamless access to cutting-edge DNA sequencing technologies to researchers from academia and industry, EASI-Genomics will support scientists to ensure compliance with the latest European and national ethical and legal requirements, secure data management and data sharing. EASI-Genomics aims at building a community of practice which leverages advanced sequencing technologies beyond country and sector borders to tackle global challenges in science.
Research institution partners of EASI Genomics:
- Centro Nacional de Análisis Genómico from the Centre for Genomic Regulation (CNAG-CRG), Spain- www.cnag.crg.eu
- Commissariat à l’énergie atomique et aux énergies alternatives (CEA-CNRGH), France http://jacob.cea.fr/drf/ifrancoisjacob/Pages/Departements/CNRGH.aspx
- Christian-Albrecht-Universität zu Kiel (CAU), Germany https://www.uni-kiel.de/de/
- Max-Delbruck Centrum fur Molekularemedizin (MDC), Germany https://www.mdc-berlin.de/
- Katholieke Universiteit Leuven (KU Leuven), Belgium https://www.kuleuven.be/english/
- Stockholm Universitet (SU), Sweden https://www.su.se/english/
- Uppsala Universitet (UU), Sweden https://www.uu.se/en
- Kunliga Tekniska Hoegskolan (KTH) SciLifeLab, Stockholm (National Genomics Infrastructure (NGI), Sweden https://www.kth.se/en and https://www.scilifelab.se/
- Deutsches Krebsforshungzentrum Heidelberg (DKFZ), Germany http://www.dkfz.de/gpcf/
- Institut National de la Santé et de la Recherche Médicale (Inserm), France http://www.u1027.inserm.fr/
- Medizinische Universitat Graz (MUG), Austria https://www.medunigraz.at/en/
- European Molecular Biology Laboratory (EMBL), Germany https://www.ebi.ac.uk/
- Tartu Ulikool (UTARTU), Estonia https://www.geenivaramu.ee/et
- Charité - Universität Berlin (CHARITE), Germany https://genomics.charite.de/
- LGC Limited (LGC)- United Kingdom https://www.lgcgroup.com/
- QIAGEN GmBH (QIAGEN GmBH), Germany https://corporate.qiagen.com/impressum
For more information and interviews, please, contact: Gloria Lligadas, Head of Communications & PR, Centre for Genomic Regulation (CRG) – firstname.lastname@example.org – Tel. +34 933160153 – Mobile +34608550788
Funding acknowledgements: This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824110